Unsafe Drugs
June 08, 2007
More Questions Than Answers About Avandia
Doctors have been flooded lately by concerned patients taking the Type 2 diabetes pill Avandia. Stephen Clement, an endocrinologist at Georgetown University, says his office has received about 30 calls from people taking Avandia. Avandia works by increasing the body's sensitivity to insulin, consequently helping to control blood sugar levels. Clement says that patients who are on the drug probably should continue to take it. However, if they are concerned, they can switch to Actos, "an alternative drug that has a similar onset of action and similar efficacy. We're leaving that up to them as an option if they want to change over."
Continue reading "More Questions Than Answers About Avandia" »
Posted by Patricia Bowling at 01:13 PM | Permalink
June 07, 2007
Contact Solution Pulled from Market
Advanced Medical Optics plans to remove Complete MoisurePlus from the market because reports of acanthamoeba keratitis have been linked to the solution. Complete MoisturePlus is used as a cleanser for soft contact lenses and also as a solution in which to store them. Acanthamoeba keratitis is caused by a parasite and can cause blindness in those who do not treat the condition.
Continue reading "Contact Solution Pulled from Market" »
Posted by Patricia Bowling at 12:56 PM | Permalink
June 06, 2007
Mother Sues Bayer Over Death of Son
Beverly Rockwell plans to seek compensatory and punitive damages on behalf of her son, Trevor A. Drake, who died after an injection of Magnevist. Rockwell claims that Magnevist, made by Bayer, was responsible for her son's death. The lawsuit alleges that the drug caused a skin and joint disease known as Nephrogenic System Fibrosis or Nephrogenic Fibrosing Dermopathy and these diseases proved fatal to Drake.
Norwalk, Ohio Mother Sues Bayer Healthcare Pharmaceuticals for the Death of Her 24-Year-Old Son
Continue reading "Mother Sues Bayer Over Death of Son" »
Posted by Patricia Bowling at 11:33 AM | Permalink
June 05, 2007
FDA Takes Action to Stop Unapproved Marketing of Guaifenesin Drugs
The U.S. Food and Drug Administration plans to stop companies that sell unapproved drug products in time-release dosage form that contain guaifenesin. Guaifenesin is a substance usually used to relieve cough and cold symptoms by causing removal of mucus from the lungs. About 20 companies currently make timed-release products that contain guaifensin that have not been reviewed by the FDA.
Action Taken to Stop Marketing of Unapproved Timed-Release Guifenesin Drug Products
Continue reading "FDA Takes Action to Stop Unapproved Marketing of Guaifenesin Drugs" »
Posted by Patricia Bowling at 11:06 AM | Permalink
June 04, 2007
China Food and Drug Administrator Sentenced to Death
China is working to cut back on corruption in its government. Case in point: China has sentenced its 62-year-old former head of the food and drug administration to death for allegedly taking bribes. Zheng Xiaoyu will be the first senior Chinese official to face the death penalty in seven years.
Death Penalty for Chinese Executive
Continue reading "China Food and Drug Administrator Sentenced to Death" »
Posted by Patricia Bowling at 10:49 AM | Permalink
